Metraipolis › archive › dc_b84792b28e0e
Optimising Therapeutic Intervals for Anti-TNF Biologics in Rheumatoid Arthritis: A Retrospective Real-World Study — Europe PMC PMID:42195279
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42195279
- DOI
- 10.3390/life16050723
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T07:30:19.433Z
- SHA-256 of the archived text
47993b9383917c068a6a433822aff0b759a4d86ce0ea4fe8ca191690cc7e0841- Stable URL of this page
https://metraipolis.com/documento/dc_b84792b28e0e
How to cite
Optimising Therapeutic Intervals for Anti-TNF Biologics in Rheumatoid Arthritis: A Retrospective Real-World Study — Europe PMC PMID:42195279 — Europe PMC (en), https://europepmc.org/article/MED/42195279 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b84792b28e0e (Metraipolis archive dc_b84792b28e0e, sha256 47993b9383917c068a6a433822aff0b759a4d86ce0ea4fe8ca191690cc7e0841)
BibTeX
@misc{dcb84792b28e0e,
title = {Optimising Therapeutic Intervals for Anti-TNF Biologics in Rheumatoid Arthritis: A Retrospective Real-World Study — Europe PMC PMID:42195279},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42195279},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b84792b28e0e; sha256 47993b9383917c068a6a433822aff0b759a4d86ce0ea4fe8ca191690cc7e0841},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195279. Agents can read the archived copy with the MCP tool read_document.